Viatris (VTRS) Operating Expenses (2019 - 2026)
Viatris (VTRS) posted quarterly Operating Expenses of $1.2 billion for Q1 2026, down 69.41% year-over-year from $4.0 billion in Q1 2025, and down 7.74% quarter-over-quarter from $1.3 billion in Q4 2025.
Viatris (VTRS) Operating Expenses (2019 - 2026) Analysis & Trends
Viatris' Operating Expenses history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Operating Expenses fell 69.41% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $4.9 billion (down 41.72% YoY), while the FY2025 annual figure was $7.7 billion, up 36.75% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
- The five-year high for Operating Expenses was $4.0 billion in Q1 2025, with the low at $1.1 billion in Q1 2022.
- The 5-year median for Operating Expenses is $1.2 billion (2023), against an average of $1.5 billion.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses jumped 211.01% in 2025, then sank 69.41% in 2026.
- Viatris' Operating Expenses stood at $1.5 billion in 2022, then soared by 39.01% to $2.1 billion in 2023, then slumped by 31.99% to $1.4 billion in 2024, then slipped by 3.89% to $1.3 billion in 2025, then dropped by 7.74% to $1.2 billion in 2026.
- Business Quant data shows VTRS's Operating Expenses at $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 4.04 Bn |
| Dec 31, 2024 | 1.39 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.69 Bn |
| Mar 31, 2024 | 1.30 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.14 Bn |
| Dec 31, 2022 | 1.48 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.15 Bn |
| Mar 31, 2022 | 1.06 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.22 Bn |